CTOs on the Move

Sara Lee Frozen Bakery

www.saraleefrozenbakery.com

 
The new Sara Lee Frozen Bakery brings together four frozen pastry brands — Sara Lee` Van’s Foods` Chef Pierre` and Bistro Collection — under independent owners and new leadership. Across the portfolio` we have recommitted to the heritage of product quality and delicious innovation that built Sara Lee from a Chicago neighborhood bakery into an iconic American brand. We can’t wait to have a new place at your table.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

Tessemae`s

Homegrown, family-owned, fun loving, brutally honest band of clean eating evangelists determined to become the global leader of fresh condiments.

Lactalis Canada

With 140 years of brand heritage, Lactalis Canada is committed to enriching and nurturing the lives of Canadians by producing nutritious and great tasting dairy products. Named on Forbes 2022 list of Canada`s Best Employers, Lactalis Canada directly employs 4,000 Canadians, supports hundreds of farming families and contributes to the livelihoods of thousands of Canadians who provide essential services to Lactalis Canada`s more than 30 operating sites including 19 manufacturing facilities. The company`s iconic brands include Cracker Barrel, Black Diamond, P`tit Québec, Balderson, Cheestrings Ficello, aMOOza!, Astro, siggi`s, Stonyfield, IÖGO, IÖGO nanö, Olympic, Lactantia, Beatrice, Galbani, and Président. Lactalis Canada`s commitment to responsible and sustainable growth has been recognized with the 2021 Canadian Grocer Impact Award for Sustainability and its CDN $2.9 million investment to the communities in which it operates. Lactalis Canada is a subsidiary of Lactalis Group, the world`s leading dairy group, headquartered in Laval, France. Lactalis Canada is an equal-opportunity employer and is committed to the principles of diversity and employment equity. Lactalis Canada strives to ensure that our workforce reflects the diverse nature of Canadian society.

Love Good Fats

Try our ridiculously delicious keto friendly, low carb, low sugar snack bars, available in 10 bars flavours & 2 shakes.

Nature`s Fynd

Nature`s Fynd is a Chicago-based food com­pa­ny creating versatile alternative proteins to nourish the world`s grow­ing population while nurturing the planet. Born out of research conducted for NASA on microbes in Yellowstone National Park, the company`s break­through technology produces Fy™. Fy is a new-to-the-world, nutritional fungi protein that only uses a frac­tion of the resources required by traditional agriculture. We use Fy to make delicious, nutritious, and sustainable meat and dairy alternatives.

Neptune Technologies and Bioressources

Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.